mproving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment.
Wisialowski TA, Ether N, Foley CM, Kleiman R, Koshman Y, Leishman D, Martel E, Nichols JV, Popp J, Rajamani S, Riley S, Rossman EI, Vargas HM.
Wisialowski TA, et al. Among authors: nichols jv.
J Pharmacol Toxicol Methods. 2024 May 20:107515. doi: 10.1016/j.vascn.2024.107515. Online ahead of print.
J Pharmacol Toxicol Methods. 2024.
PMID: 38777240
No abstract available.